Neutrophil Count Is Associated With Reduced Gray Matter and Enlarged Ventricles in First-Episode Psychosis.


Journal

Schizophrenia bulletin
ISSN: 1745-1701
Titre abrégé: Schizophr Bull
Pays: United States
ID NLM: 0236760

Informations de publication

Date de publication:
18 06 2019
Historique:
pubmed: 15 8 2018
medline: 1 7 2020
entrez: 15 8 2018
Statut: ppublish

Résumé

Although there is recent evidence that cells from the peripheral immune system can gain access to the central nervous system in certain conditions such as multiple sclerosis, their role has not been assessed in psychosis. Here, we aimed to explore whether blood cell count was associated with brain volume and/or clinical symptomatology. A total of 218 participants (137 first-episode psychosis patients [FEP] and 81 healthy controls [HC]) were included in the study. For each participant, a T1 structural image was acquired, from which brain tissue volumes were calculated. We found that, in FEP, neutrophil count was associated with reduced gray matter (GM) volume (β = -0.117, P < .001) and increased cerebrospinal fluid volume (β = 0.191, P = .007). No associations were observed in HC. GM reduction was generalized but more prominent in certain regions, notably the thalamus, the anterior insula, and the left Heschl's gyrus, among many others. Neutrophil count was also associated with the total PANSS score (β = 0.173, P = .038), including those items assessing hallucinations (β = 0.182, P = .028) and avolition (β = 0.197, P = .018). Several confounders, such as antipsychotic medication, body mass index, and smoking, were controlled for. Overall, the present study may represent the first indirect evidence of brain tissue loss associated with neutrophils in psychosis, and lends support to the hypothesis of a dysregulated immune system. Higher neutrophil count was also associated with more severe clinical symptomatology, which renders it a promising indicator of schizophrenia severity and could even give rise to new therapies.

Identifiants

pubmed: 30107610
pii: 5068900
doi: 10.1093/schbul/sby113
pmc: PMC6581126
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

846-858

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

JAMA Psychiatry. 2015 Nov;72(11):1095-101
pubmed: 26444987
Neuron. 2015 Jul 1;87(1):47-62
pubmed: 26139369
Nat Med. 2015 Aug;21(8):880-6
pubmed: 26214837
Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):E5665-74
pubmed: 27601660
J Cereb Blood Flow Metab. 2012 Apr;32(4):598-611
pubmed: 22293986
Immunol Cell Biol. 2005 Feb;83(1):9-17
pubmed: 15661036
Transfus Med Hemother. 2012 Oct;39(5):353-61
pubmed: 23801928
Neurobiol Aging. 2014 Jun;35(6):1286-92
pubmed: 24485508
Brain Res. 2001 Jan 5;888(1):117-127
pubmed: 11146058
J Cereb Blood Flow Metab. 2009 Sep;29(9):1503-16
pubmed: 19471279
Am J Psychiatry. 2004 Jan;161(1):154-6
pubmed: 14702264
Schizophr Bull. 2016 Mar;42(2):344-57
pubmed: 26371339
Proc Natl Acad Sci U S A. 2016 Mar 1;113(9):E1316-25
pubmed: 26884167
Nat Med. 2014 Jul;20(7):754-758
pubmed: 24952646
Transl Psychiatry. 2016 Dec 13;6(12):e982
pubmed: 27959331
Biol Psychiatry. 1994 Feb 1;35(3):210-3
pubmed: 8173023
Stroke. 2004 Jul;35(7):1659-64
pubmed: 15155970
Nat Rev Immunol. 2017 Apr;17(4):248-261
pubmed: 28287106
Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):17648-53
pubmed: 25422429
J Clin Psychopharmacol. 2017 Aug;37(4):456-458
pubmed: 28590372
Vet Res. 2011 Jul 29;42:89
pubmed: 21801407
Transl Psychiatry. 2012 Nov 20;2:e190
pubmed: 23168990
Biol Psychiatry. 2011 Oct 1;70(7):663-71
pubmed: 21641581
Proc Natl Acad Sci U S A. 2013 May 7;110(19):7726-31
pubmed: 23610437
Stroke. 2008 Feb;39(2):355-60
pubmed: 18162626
J Nerv Ment Dis. 2017 Nov;205(11):893-895
pubmed: 29077651
Neurosci Res. 1991 Apr;10(3):211-21
pubmed: 1650437
J Neuroimaging. 1999 Oct;9(4):201-9
pubmed: 10540599
Eur J Immunol. 2010 Aug;40(8):2340-8
pubmed: 20540117
FEBS Lett. 2011 Dec 1;585(23):3770-80
pubmed: 21550344
J Cereb Blood Flow Metab. 2016 Jul;36(7):1304-15
pubmed: 27146513
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Schizophr Res. 2000 Jul 7;44(1):1-10
pubmed: 10867307
Arch Gen Psychiatry. 2003 Aug;60(8):766-75
pubmed: 12912760
Neurosci Lett. 2007 Dec 11;429(1):7-11
pubmed: 17996370
Schizophr Res. 2018 Feb;192:69-74
pubmed: 28412089
J Neuroinflammation. 2012 Aug 07;9:187
pubmed: 22870891
Trends Immunol. 2015 Oct;36(10):651-662
pubmed: 26431942
Compr Psychiatry. 2016 Aug;69:169-78
pubmed: 27423358
Schizophr Bull. 2010 Mar;36(2):359-69
pubmed: 18644851
Transl Psychiatry. 2017 Mar 28;7(3):e1075
pubmed: 28350400
Neuroscience. 2003;122(4):853-67
pubmed: 14643756
J Neuropathol Exp Neurol. 2000 Feb;59(2):137-50
pubmed: 10749103
Nat Neurosci. 2017 Feb;20(2):136-144
pubmed: 28092660
Mol Psychiatry. 2016 Aug;21(8):1090-8
pubmed: 26194183
Schizophr Res. 2003 May 1;61(1):47-57
pubmed: 12648735
J Exp Med. 2017 Nov 6;214(11):3151-3169
pubmed: 29061693
J Child Adolesc Psychopharmacol. 2014 Nov;24(9):494-500
pubmed: 24828326
Biochim Biophys Acta. 2016 Mar;1862(3):329-38
pubmed: 26584587
Br J Pharmacol. 2016 Feb;173(4):666-80
pubmed: 26455353
J Cereb Blood Flow Metab. 2015 Jun;35(6):888-901
pubmed: 25806703
J Clin Epidemiol. 2001 Apr;54(4):343-9
pubmed: 11297884
Schizophr Bull. 2015 Jan;41(1):85-93
pubmed: 25385788
Acta Neuropathol. 2006 Sep;112(3):305-16
pubmed: 16783554
Mol Psychiatry. 2013 Feb;18(2):206-14
pubmed: 22869038
J Neuroinflammation. 2012 Jan 23;9:17
pubmed: 22269349
Early Interv Psychiatry. 2019 Feb;13(1):95-100
pubmed: 28786532
Biol Psychiatry. 2015 Jan 15;77(2):147-57
pubmed: 25034946
Curr Trends Immunol. 2015;16:65-78
pubmed: 27818580
Int J Mol Sci. 2017 Aug 12;18(8):
pubmed: 28805697
Neurosci Biobehav Rev. 2015 Aug;55:612-26
pubmed: 26092265
Neuropsychopharmacology. 2010 Jul;35(8):1743-50
pubmed: 20357761
J Psychiatr Res. 2008 Jan;42(2):151-7
pubmed: 17174336
Neuron. 1999 Mar;22(3):615-21
pubmed: 10197540
Schizophr Bull. 2013 Nov;39(6):1174-9
pubmed: 24072812

Auteurs

Christian Núñez (C)

Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain.
Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain.

Christian Stephan-Otto (C)

Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain.
Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain.

Judith Usall (J)

Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain.
Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain.

Miquel Bioque (M)

Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain.
Barcelona Clínic Schizophrenia Unit, Neuroscience Institute, Hospital Clínic de Barcelona, Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Antonio Lobo (A)

Department of Medicine and Psychiatry, Instituto de Investigación Sanitaria Aragón, Universidad de Zaragoza, Zaragoza, Spain.

Ana González-Pinto (A)

International Mood Disorders Research Centre, Hospital Santiago Apóstol, University of the Basque Country, Vitoria, Spain.

Laura Pina-Camacho (L)

Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain.
Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, IiSGM, Madrid, Spain.

Eduard Vieta (E)

Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain.
Psychiatry Department, Hospital Clínic de Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain.

Josefina Castro-Fornieles (J)

Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Child and Adolescent Psychiatry and Psychology Department, Clinic Institute of Neurosciences, Hospital Clínic de Barcelona, Barcelona, Spain.
Department of Medicine, University of Barcelona, Barcelona, Spain.

Roberto Rodriguez-Jimenez (R)

Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.

Anna Butjosa (A)

Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain.
Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain.

Joost Janssen (J)

Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain.
Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, IiSGM, Madrid, Spain.
Brain Center Rudolf Magnus, Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands.

Bibiana Cabrera (B)

Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain.
Barcelona Clínic Schizophrenia Unit, Neuroscience Institute, Hospital Clínic de Barcelona, Barcelona, Spain.

Mara Parellada (M)

Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain.
Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, IiSGM, Madrid, Spain.

Miquel Bernardo (M)

Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain.
Barcelona Clínic Schizophrenia Unit, Neuroscience Institute, Hospital Clínic de Barcelona, Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH